BONESUPPORT entered into an agreement with Collagen Matrix to expand its U.S. offering with products complementary to CERAMENT BVF. In 4Q18, BONESUPPORT will commence sales of Collagen Matrix bone graft substitute products under the BONESUPPORT brand, and through its own U.S. distribution network.
Per Emil Billbäck, CEO of BONESUPPORT, “Collagen Matrix products can be osteoinductive and osteogenic when combined with bone marrow aspirate, making them complementary to CERAMENT BVF, which is osteoconductive.” Further, he added, “Establishing a broader portfolio of bone graft substitute technologies will also significantly improve our competitive position with payors including Group Purchasing Organization/Integrated Delivery Networks.”
Collagen Matrix products, when combined with autogenous bone marrow, are both osteoinductive and osteogenic.
Earlier this month, BONESUPPORT announced termination of its present exclusive U.S. distribution agreement with Zimmer Biomet and creation of its own U.S. commercial organization to support current and future U.S. product launches.
BONESUPPORT entered into an agreement with Collagen Matrix to expand its U.S. offering with products complementary to CERAMENT BVF. In 4Q18, BONESUPPORT will commence sales of Collagen Matrix bone graft substitute products under the BONESUPPORT brand, and through its own U.S. distribution network.
Per Emil Billbäck, CEO of BONESUPPORT,...
BONESUPPORT entered into an agreement with Collagen Matrix to expand its U.S. offering with products complementary to CERAMENT BVF. In 4Q18, BONESUPPORT will commence sales of Collagen Matrix bone graft substitute products under the BONESUPPORT brand, and through its own U.S. distribution network.
Per Emil Billbäck, CEO of BONESUPPORT, “Collagen Matrix products can be osteoinductive and osteogenic when combined with bone marrow aspirate, making them complementary to CERAMENT BVF, which is osteoconductive.” Further, he added, “Establishing a broader portfolio of bone graft substitute technologies will also significantly improve our competitive position with payors including Group Purchasing Organization/Integrated Delivery Networks.”
Collagen Matrix products, when combined with autogenous bone marrow, are both osteoinductive and osteogenic.
Earlier this month, BONESUPPORT announced termination of its present exclusive U.S. distribution agreement with Zimmer Biomet and creation of its own U.S. commercial organization to support current and future U.S. product launches.
Copy to clipboard 
